Location History:
- Newton Square, PA (US) (2006 - 2010)
- Newtown Square, PA (US) (1997 - 2018)
Company Filing History:
Years Active: 1997-2018
Title: Innovations by Bernhard Dietzschold: Pioneering Advances in Immunization
Introduction
Bernhard Dietzschold, an accomplished inventor based in Newtown Square, PA, has made significant contributions to the field of immunization, holding a total of 11 patents. His work primarily focuses on the development of innovative rabies virus vectors expressing foreign protein antigens, which aim to enhance immune responses in subjects.
Latest Patents
Dietzschold's latest patents showcase groundbreaking advancements in immunization. One notable patent revolves around a regimen that utilizes an attenuated recombinant rabies virus, which encodes foreign protein antigens. This innovative approach not only elicits an immune response but also employs a prime/boost strategy that produces predominantly IgG 2A/C and IgG 2B antibodies, indicating a robust TH1 response. Additionally, his invention of an attenuated live triple G protein recombinant rabies virus focuses on pre- and post-exposure prophylaxis of rabies. The recombinant viruses consist of three copies of a mutated G gene, enhancing their safety and efficacy by being nonpathogenic in immunodeficient mammals while effectively inducing immunity.
Career Highlights
Throughout his career, Dietzschold has collaborated with reputable institutions such as Thomas Jefferson University and The Wistar Institute. His work in these organizations has solidified his position as a thought leader in the field of virology and immunology.
Collaborations
Dietzschold has worked alongside esteemed colleagues like Douglas Craig Hooper and Hilary Koprowski. Their collaborations have contributed significantly to advancing knowledge and developing innovative solutions in the realm of vaccines and immunization strategies.
Conclusion
With his 11 patents and impactful contributions to the field of immunology, Bernhard Dietzschold continues to push the boundaries of innovation. His dedication to enhancing vaccine efficacy and safety is paving the way for better health outcomes and greater protection against infectious diseases.